Long-term follow-up of patients after related-and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia
E Reiter, HT Greinix, F Keil, S Brugger, W Rabitsch… - Annals of …, 1999 - Springer
Abstract Between January 1983 and December 1997, 88 patients (36 female, 52 male,
median age 37 years, range 19–57) with chronic myelogenous leukemia (CML) underwent …
median age 37 years, range 19–57) with chronic myelogenous leukemia (CML) underwent …
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
E Reiter, HT Greinix, S Brugger, F Keil… - Bone marrow …, 1998 - europepmc.org
Between January 1983 and July 1997, 83 patients (35 female, 48 male) with a median age
of 37 (19-57) years with chronic myelogenous leukemia (CML) were admitted for bone …
of 37 (19-57) years with chronic myelogenous leukemia (CML) were admitted for bone …
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program
PB McGlave, XO Shu, W Wen… - Blood, The Journal …, 2000 - ashpublications.org
Over a period of 8.5 years (February 1988 to October 1996), 1423 patients with chronic
myelogenous leukemia (CML) underwent unrelated donor (URD) bone marrow transplants …
myelogenous leukemia (CML) underwent unrelated donor (URD) bone marrow transplants …
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
MR Bishop, PJ Henslee-Downey… - Bone marrow …, 1996 - europepmc.org
From 1987 to 1991, 26 patients with CML and a median age of 31 years received allogeneic
BMT from a partially mismatched related donor (PMRD) who shared at least one haplotype …
BMT from a partially mismatched related donor (PMRD) who shared at least one haplotype …
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience
T Lamparelli, MT Van Lint, F Gualandi… - Bone marrow …, 1997 - nature.com
This is a report on 60 consecutive patients with chronic myeloid leukemia (CML) who
received an allogeneic bone marrow transplant (BMT) in this Unit. Donors were HLA …
received an allogeneic bone marrow transplant (BMT) in this Unit. Donors were HLA …
Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results
D Gaziev, M Galimberti, P Polchi, E Angelucci… - Bone marrow …, 2002 - nature.com
Abstract From April 1981 to February 2000, 105 patients with chronic myeloid leukemia
(CML) underwent BMT from HLA-identical related donors at a single center. Eighty-eight …
(CML) underwent BMT from HLA-identical related donors at a single center. Eighty-eight …
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation
DJ Weisdorf, C Anasetti, JH Antin… - Blood, The Journal …, 2002 - ashpublications.org
Allogeneic bone marrow transplantation (BMT) offers the only curative therapy for chronic
myelogenous leukemia. We compared prospectively collected results of 2464 unrelated …
myelogenous leukemia. We compared prospectively collected results of 2464 unrelated …
Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience
J Vela-Ojeda, F Tripp-Villanueva… - Archives of Medical …, 2000 - Elsevier
BACKGROUND: Bone marrow transplantation (BMT) is the therapy of choice for patients
with chronic myeloid leukemia (CML) who have a human leukocyte antigen (HLA)-identical …
with chronic myeloid leukemia (CML) who have a human leukocyte antigen (HLA)-identical …
Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.
P McGlave - Seminars in hematology, 1990 - europepmc.org
The success of bone marrow transplantation in chronic myelogenous leukemia (CML) is
strongly associated with the phase of the disease at the time of transplantation. For …
strongly associated with the phase of the disease at the time of transplantation. For …
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease
R Storb, HJ Deeg, ED Thomas, FR Appelbaum… - 1985 - ashpublications.org
Forty-eight patients with chronic myelocytic leukemia, aged 11 to 47, were treated with high-
dose cyclophosphamide and fractionated total body irradiation, followed by infusion of …
dose cyclophosphamide and fractionated total body irradiation, followed by infusion of …